Pursuit Vascular, Inc. is a privately held medical device company located in Maple Grove, Minnesota, a suburb of Minneapolis. The company is developing a family of innovative single-use products designed to protect patients from life-threatening infections associated with long-term catheter and port use, while reducing costs of health care.
Based on its patented ClearGuard® technology, the company’s first product, the ClearGuard HD Antimicrobial Barrier Cap, targets microorganisms associated with hemodialysis catheter infections. This simple yet revolutionary device has been cleared for sale by the U.S. Food and Drug Administration. Two large-scale randomized clinical trials were recently completed with the largest hemodialysis providers in the U.S. With the success of ClearGuard HD serving as a solid foundation for future growth, the company plans to introduce additional unique solutions for other large and growing patient populations.
We are dedicated to developing and delivering products of the highest quality to aid in the prevention of catheter-related infection and inflammatory diseases, and the associated illness and death, both in the US and worldwide.
American Journal of Kidney Diseases (AJKD)
Editors' Choice Award 2017
Eureka! Innovation Award – honors Minnesota companies
revolutionizing their industries 2017
Medical Design Excellence Award – The medical technology industry's
premier design competition
Drug-Delivery Devices and Combination Products Winner 2016
Tekne Award – Minnesota’s premiere award for Innovation in Technology
Life Science Winner 2011
MN Cup – the largest statewide new venture competition in the United States
Life Science / Health IT Division Winner 2009